Ketoconazole and Rash maculo-papular - a phase IV clinical study of FDA data

Summary:

Rash maculo-papular is reported as a side effect among people who take Ketoconazole (ketoconazole), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Triamcinolone, and have Gout.

The phase IV clinical study analyzes which people have Rash maculo-papular when taking Ketoconazole. It is created by eHealthMe based on reports of 15,751 people who have side effects when taking Ketoconazole from the FDA, and is updated regularly.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,243 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

On Jul, 19, 2026

15,751 people reported to have side effects when taking Ketoconazole.
Among them, 27 people (0.17%) have Rash maculo-papular.

Could Ketoconazole cause Rash maculo-papular?

Among these 27 people:

How long have people been on Ketoconazole when they have Rash maculo-papular? *

What is the gender of people who have Rash maculo-papular when taking Ketoconazole? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Rash maculo-papular when taking Ketoconazole? *

What are other drugs people take besides Ketoconazole? *

What are other side effects people have besides Rash maculo-papular? *

Rashes (redness): 7 people, 25.93%
Nausea (feeling of having an urge to vomit): 6 people, 22.22%
Diarrhea: 5 people, 18.52%
Rash Erythematous (redness of the skin): 5 people, 18.52%
Mouth Ulcers: 5 people, 18.52%
Erythema Multiforme (a type of hypersensitivity reaction): 5 people, 18.52%
Fever: 4 people, 14.81%
Liver Function Test Abnormal: 4 people, 14.81%
Scab (a hard coating on the skin formed during the wound healing): 4 people, 14.81%
Itching: 4 people, 14.81%

What are the existing conditions these people have? *

Gout (uric acid crystals building up in the body): 4 people, 14.81%
Nausea (feeling of having an urge to vomit): 3 people, 11.11%
Urinary Tract Infection: 2 people, 7.41%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 7.41%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.41%
Cough: 2 people, 7.41%
Drowsiness: 2 people, 7.41%
Dyspnea (difficult or laboured breathing): 2 people, 7.41%
Fever: 2 people, 7.41%
Hiv Infection: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoconazole and have Rash maculo-papular?

- Check whether Rash maculo-papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ketoconazole:

Ketoconazole (16,014 reports)

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash maculo-papular:

Rash maculo-papular (1,243 drugs)

Browse all the conditions that are associated with Rash maculo-papular:

Rash maculo-papular (1,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketoconazole (the active ingredients of Ketoconazole) and Ketoconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.